EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells.

Liu, Chun-Yu

EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. [electronic resource] - European journal of cancer (Oxford, England : 1990) 02 2017 - 112-123 p. digital

Publication Type: Journal Article

1879-0852

10.1016/j.ejca.2016.11.012 doi


Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Autoantigens--genetics
Disease Models, Animal
ErbB Receptors--metabolism
Erlotinib Hydrochloride--pharmacology
Heterografts
Humans
Intracellular Signaling Peptides and Proteins
Membrane Proteins--genetics
Mice
Mice, Nude
RNA, Messenger--metabolism
Signal Transduction--drug effects
Triple Negative Breast Neoplasms--drug therapy
Tumor Cells, Cultured
ets-Domain Protein Elk-1--genetics